XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stockholders' Equity

Note 16. Stockholders' Equity

Equity-Based Compensation

On July 20, 2021, the Board of Directors approved the P10 Holdings, Inc. 2021 Stock Incentive Plan (the "Plan"), which replaced the 2018 Incentive Plan, our previously existing equity compensation plan. The Plan provides for the issuance of 3,000,000 shares available for grant, in addition to those approved in the 2018 Incentive Plan ("2018 Plan"), for a total of 9,300,000 shares (previously unadjusted for the stock split of 12,000,000). The Compensation Committee of the Board of Directors may issue equity-based awards including stock options, stock appreciation rights, restricted stock units and restricted stock awards. Options previously granted under the 2018 Incentive Plan vest over a period of up to five years. The term of each option is no more than ten years from the date of grant. When the options are exercised, the Board of Directors has the option of issuing shares of common stock or paying a lump sum cash payment on the exercise date equal to the

difference between the common stock’s fair market value on the exercise date and the option price. All future awards will be granted under the Plan, and no additional awards will be granted under the 2018 Plan.

On March 15, 2022, the Board of Directors approved the settlement of 1.1 million options from a grantee with a fair market value option price of $11.83, less a negotiated discount of 2.5%, totaling $12.5 million. This is presented in other liabilities on the Consolidated Balance Sheets.

A summary of stock option activity for the period ended March 31, 2022 is as follows:

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Contractual Life

 

 

Aggregate

 

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

 

Intrinsic Value

 

 

 

Shares

 

 

Exercise Price

 

 

(in years)

 

 

(whole dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

7,095,936

 

 

$

3.71

 

 

 

7.45

 

 

$

73,156,722

 

Granted

 

 

1,323,733

 

 

 

12.28

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Settled

 

 

(1,120,000

)

 

 

0.41

 

 

 

 

 

 

 

Expired/Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2022

 

 

7,299,669

 

 

$

5.95

 

 

 

8.08

 

 

$

43,865,350

 

Exercisable as of March 31, 2022

 

 

363,445

 

 

$

4.09

 

 

 

6.67

 

 

$

2,920,165

 

 

The weighted average assumptions used in calculating the fair value of stock options granted during the three months ended March 31, 2022 and March 31, 2021 were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Expected life

 

7.5 (yrs)

 

 

7.5 (yrs)

 

Expected volatility

 

 

35.40

%

 

 

41.70

%

Risk-free interest rate

 

 

1.83

%

 

 

0.79

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

The Company has granted restricted stock awards ("RSAs") to certain employees. Holders of RSAs have no voting rights and are not eligible to receive dividends or other distributions paid with respect to any RSAs that have not vested. All of the shares currently vest one year from the grant date.

 

 

 

Number of

 

 

Weighted-Average Grant

 

 

 

RSAs

 

 

Date Fair Value Per RSA

 

Outstanding as of December 31, 2021

 

 

36,033

 

 

$

11.24

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding as of March 31, 2022

 

 

36,033

 

 

$

11.24

 

 

The Company has granted restricted stock units ("RSUs") to certain employees. Holders of RSUs have no voting rights and are not eligible to receive dividends or other distributions paid with respect to any RSUs that have not vested. All of the shares currently vest one year from the grant date.

 

 

 

Number of

 

 

Weighted-Average Grant

 

 

 

RSUs

 

 

Date Fair Value Per RSU

 

Outstanding as of December 31, 2021

 

 

59,654

 

 

$

12.74

 

Granted

 

 

508,135

 

 

 

12.30

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding as of March 31, 2022

 

 

567,789

 

 

$

12.35

 

 

 

Compensation expense equal to the grant date fair value is recognized for these awards over the vesting period and is included in compensation and benefits on our Consolidated Statements of Operations. The stock-based compensation expense was $1.5 million and $0.4 million for the three months ended March 31, 2022 and March 31, 2021, respectively. Unrecognized stock-based compensation expense related to outstanding unvested stock options as of March 31, 2022 was $7.5 million and is expected to be recognized over a weighted average period of 3.05 years. Any future forfeitures will impact this amount.